88 related articles for article (PubMed ID: 8446243)
1. Calcium acetate versus calcium carbonate as phosphate binders.
Ring T
Nephron; 1993; 63(1):119. PubMed ID: 8446243
[No Abstract] [Full Text] [Related]
2. Efficient phosphate binding using a combination of gluconolactate and carbonate calcium salts.
Legendre JY; Cote S; Pradeau D; Hamon M; Vitzling C; Lavene D; Tarral A
J Clin Pharm Ther; 1994 Aug; 19(4):233-8. PubMed ID: 7989401
[TBL] [Abstract][Full Text] [Related]
3. Calcium beta-hydroxy-beta-methylbutyrate. 1. Potential role as a phosphate binder in uremia: in vitro study.
Sousa MF; Abumrad NN; Martins C; Nissen S; Riella MC
Nephron; 1996; 72(3):391-4. PubMed ID: 8852485
[TBL] [Abstract][Full Text] [Related]
4. Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders.
Noto L
J Ren Nutr; 2011 May; 21(3):277-82. PubMed ID: 20598905
[TBL] [Abstract][Full Text] [Related]
5. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
[TBL] [Abstract][Full Text] [Related]
6. Calcium acetate versus calcium carbonate as phosphorus binders in patients on chronic haemodialysis: a controlled study.
Ring T; Nielsen C; Andersen SP; Behrens JK; Sodemann B; Kornerup HJ
Nephrol Dial Transplant; 1993; 8(4):341-6. PubMed ID: 8390009
[TBL] [Abstract][Full Text] [Related]
7. Effect of phosphate binders upon TSH and L-thyroxine dose in patients on thyroid replacement.
Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
Int Urol Nephrol; 2007; 39(2):599-602. PubMed ID: 17216296
[TBL] [Abstract][Full Text] [Related]
8. Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study.
Sheikh MS; Maguire JA; Emmett M; Santa Ana CA; Nicar MJ; Schiller LR; Fordtran JS
J Clin Invest; 1989 Jan; 83(1):66-73. PubMed ID: 2910921
[TBL] [Abstract][Full Text] [Related]
9. Can omeprazole reduce the incidence of hypercalcemia in dialysis patients using calcium containing phosphate binders?
Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
J Nephrol; 2010; 23(4):438-43. PubMed ID: 20349423
[TBL] [Abstract][Full Text] [Related]
10. Alternative phosphate binders: an update.
Schaefer K
Nephrol Dial Transplant; 1993; 8 Suppl 1():35-9. PubMed ID: 8389018
[No Abstract] [Full Text] [Related]
11. Calcium acetate versus calcium carbonate as phosphate binders in hemodialysis patients.
Caravaca F; Santos I; Cubero JJ; Esparrago JF; Arrobas M; Pizarro JL; Robles R; Sanchez-Casado E
Nephron; 1992; 60(4):423-7. PubMed ID: 1584317
[TBL] [Abstract][Full Text] [Related]
12. Calcium carbonate as phosphate binder in patients on low-calcium dialysate.
Daelemans R; Verhelst JA; Moorkens GH; Zachée P; Lins RL
Am J Nephrol; 1989; 9(4):348. PubMed ID: 2817021
[No Abstract] [Full Text] [Related]
13. Phosphate binders.
Med Lett Drugs Ther; 2006 Feb; 48(1228):15-6. PubMed ID: 16467735
[No Abstract] [Full Text] [Related]
14. Effect of omeprazole on the phosphate-binding capacity of calcium carbonate.
Osler P; Raniga P; Farrington K
Nephron; 1995; 69(1):89-90. PubMed ID: 7891806
[No Abstract] [Full Text] [Related]
15. Phosphate binders in hyperphosphatemia of chronic renal failure.
Wasan SM; Godley PJ
DICP; 1991 Sep; 25(9):942-5. PubMed ID: 1949972
[No Abstract] [Full Text] [Related]
16. Control of predialytic hyperphosphatemia by oral calcium acetate and calcium carbonate. Comparable efficacy for half the dose of elemental calcium given as acetate without lower incidence of hypercalcemia.
Morinière P; Djerad M; Boudailliez B; el Esper N; Boitte F; Westeel PF; Compagnon M; Brazier M; Achard JM; Fournier A
Nephron; 1992; 60(1):6-11. PubMed ID: 1738415
[TBL] [Abstract][Full Text] [Related]
17. Phosphate-binding capacities of calcium and aluminum formulations.
Lau AH; Kuk JM; Franson KL
Int J Artif Organs; 1998 Jan; 21(1):19-22. PubMed ID: 9554821
[TBL] [Abstract][Full Text] [Related]
18. Long-term (6 months) cross-over comparison of calcium acetate with calcium carbonate as phosphate binder.
Ben Hamida F; el Esper I; Compagnon M; Morinière P; Fournier A
Nephron; 1993; 63(3):258-62. PubMed ID: 8446261
[TBL] [Abstract][Full Text] [Related]
19. [A comparison of phosphorus-chelating effect of calcium carbonate versus calcium acetate before dialysis].
Borrego J; Pérez del Barrio P; Serrano P; García Cortés MJ; Sánchez Perales MC; Borrego FJ; Liébana A; Gil Cunquero JM; Pérez Bañasco V
Nefrologia; 2000; 20(4):348-54. PubMed ID: 11039260
[TBL] [Abstract][Full Text] [Related]
20. Medication review: an alternative phosphate binder--calcium acetate.
Holechek MJ
ANNA J; 1991 Jun; 18(3):321-2. PubMed ID: 2064459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
